HOME >> MEDICINE >> NEWS
Beneficiaries with chronic conditions still face high costs under new Medicare drug law

New York City, June 1, 2004--The new Medicare prescription drug law will provide much-needed help to many, especially beneficiaries with low incomes, but it's unclear whether most patients will benefit in the long run, a new Commonwealth Fund report says.

The drug benefits provided under the measure will not grow with beneficiaries' needs, and other program changes that could prove unworkable or place some beneficiaries at risk will create added costs, the report says. In the meantime, reliance on standalone private drug plans could saddle beneficiaries remaining in traditional Medicare with higher costs.

In How Beneficiaries Fare Under the New Medicare Drug Bill, Marilyn Moon of the American Institutes for Research analyzes the complexities of the Medicare Prescription Drug Improvement and Modernization Act (MMA), highlighting potential pitfalls for beneficiaries. The lack of aid for those with incomes just over the limit for low-income assistance will need close monitoring to determine their effect on beneficiaries over time, Moon says. Additional legislation and carefully crafted regulations will be key to ensuring the success of the benefit, she concludes.

"The MMA is the largest benefit expansion in Medicare's history, and creates major changes in the program's structure," said Moon. "There is a great deal of uncertainty about whether the benefit is well-designed to provide beneficiaries with access to needed medications while providing protection from high out-of-pocket costs."

Chronically Ill Will Bear Greatest Burden of Coverage Gap
About two in five (42%) Medicare beneficiaries have drug expenditures of more than $2,251 a year and will therefore be affected by the coverage gap, or "donut hole," that occurs between $2,251 and $5,100 in total drug spending.

Many affected by the gap are expected to be those with chronic conditions: about three-fourths of Medicare beneficiaries have two or more chronic cond
'"/>

Contact: Mary Mahon
mm@cmwf.org
212-606-3853
Commonwealth Fund
1-Jun-2004


Page: 1 2

Related medicine news :

1. UMaine study looks at infants and chronic nighttime crying
2. Study finds that coordinating care of chronically ill patients does not increase liability
3. Study finds new designer drug is potent treatment for chronic myelogenous leukemia
4. Vaccine may complement conventional treatment for chronic leukaemia
5. Study finds new designer drug is potent treatment for chronic myelogenous leukemia
6. Activity not out of the question for people with chronic pain
7. Generation gap found in chronic pain
8. No advantage of combination drug therapy for chronic hepatitis B Infection
9. Few Americans are aware they have chronic kidney disease
10. Few Americans aware they have chronic kidney disease
11. Elderly with advanced chronic diseases burdened with symptoms

Post Your Comments:
(Date:5/29/2015)... York, NY (PRWEB) May 29, 2015 ... USA Today, with a circulation of approximately 250,000 and ... distributed nationally, through a vast social media strategy, and ... outlets. To explore the digital version of the campaign, ... cover of the print publication. Inside, the actress, model ...
(Date:5/29/2015)... Vancouver, BC (PRWEB) May 29, 2015 ... PhysioCare & Sports Rehab, has recently stated in a ... “hide and suffer”. Urinary Continence is commonly seen as ... hesitate before seeking help. Expert physiotherapists like Shaila Jiwa ... about the condition. , Incontinence is a condition ...
(Date:5/29/2015)... 2015 Dr. Rodger Murphree, author ... Syndrome is now offering free weekly call in ... natural ways to reduce symptoms associated with fibromyalgia ... and brain fog. , To find out ... Fibromyalgia call in teleconferences simply go to ...
(Date:5/29/2015)... 2015 Javlin continues to fulfill its ... and a larger team, with the intention to better ... share in the U.S. and Canada. , Javlin Inc., ... significant growth in 2014 with its strongest earnings to ... integration platform, CloverETL. To accelerate further progress and ensure ...
(Date:5/29/2015)... 29, 2015 The FSH ... the science of the little-known and incurable disease, ... co-funding the second FSHD Trial Preparedness Workshop. The ... the University of Rochester Medical Center in Rochester, ... from around the world, including representatives from industry, ...
Breaking Medicine News(10 mins):Health News:Patients of Urinary Incontinence Should Not "Hide And Suffer," States Physiotherapist from Burnaby Physiotherapy Clinic 2Health News:Growth of Data Integration Platform CloverETL Continues in North America 2Health News:International Conference Brings Together Key Stakeholders to Advance Clinical Trial Readiness for FSHD 2Health News:International Conference Brings Together Key Stakeholders to Advance Clinical Trial Readiness for FSHD 3
(Date:5/29/2015)... 2015  Dr. Yair Walzer has added a ... issues often caused by menopause. The MonaLisa Touch™, an in-office ... FDA clearance in 2014. Dr. Walzer is one of the ... the special fractional CO 2 laser specifically designed to ... In 2010 there were greater than 46M women ...
(Date:5/29/2015)... South Carolina , May 29, 2015 ... have announced a collaboration designed to provide therapeutic clinical ... majority of cancer patients living in U.S. communities. ... Health to harness the power of big data and ... thousands of patients to enable ,accrual on demand, for ...
(Date:5/29/2015)... , May 29, 2015 /CNW/ - Covalon Technologies ... advanced medical technologies company, is delighted to announce ... March 31, 2015, which includes revenue for three ... quarter of $264,340. Revenue from advanced wound care product ... 31, 2015 increased 24% to $1,742,672 compared to ...
Breaking Medicine Technology:The Newest FDA-Cleared Breakthrough In Women's Health Treatments 2New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 2New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 3New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 4Covalon Announces Strong Second Quarter Results 2Covalon Announces Strong Second Quarter Results 3
Cached News: